BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15035151)

  • 21. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis.
    Eastell R; Colwell A; Hampton L; Reeve J
    J Bone Miner Res; 1997 Jan; 12(1):59-65. PubMed ID: 9240726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bone resorption marker].
    Kitatani K; Nakatsuka K
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():243-8. PubMed ID: 11979914
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
    Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
    J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary excretion of free and total deoxypyridinoline during secondary hyperparathyroidism in the elderly. Comparison of chromatographic (HPLC) and immunoenzymatic (Pyrilinks-D) methods].
    Meddah B; Brazier M; Kamel S; Maamer M; Samson L; Desmet G; Sebert JL
    Ann Biol Clin (Paris); 1996; 54(10-11):353-8. PubMed ID: 9092303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of the new biochemical markers of bone metabolism].
    Rodríguez Espinosa J; Queraltó Compañó JM
    Med Clin (Barc); 1998 Sep; 111(7):259-62. PubMed ID: 9789241
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reference values of assayable pyridinolines as markers of bone turn-over].
    Zolezzi C; Lenzi L; Salizzoni MP; Pizzoferrato A
    Minerva Med; 1995; 86(1-2):5-9. PubMed ID: 7753439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK; Brazier M; Mathiot C; Kamel S; Jamart J; Jaubert J; Blanc M; Azaïs I; Facon T; Leleu X
    Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Absolute risk for fracture and WHO guideline. Bone turnover markers as predictive factors for osteoporotic fractures].
    Yoshimura N;
    Clin Calcium; 2007 Jul; 17(7):1049-57. PubMed ID: 17607072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract]   [Full Text] [Related]  

  • 32. Standardization of marker assays--pyridinoline/deoxypyridinoline.
    Kent GN
    Scand J Clin Lab Invest Suppl; 1997; 227():73-9. PubMed ID: 9127470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of vitamin K2 and estrogen administration on bone formation].
    Aisaka K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():484-7. PubMed ID: 15035176
    [No Abstract]   [Full Text] [Related]  

  • 34. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pyridinoline, deoxypyridinoline].
    Ishikawa T; Okazaki R
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():224-7. PubMed ID: 15658305
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
    Asaba Y; Hiramatsu K; Matsui Y; Harada A; Nimura Y; Katagiri N; Kobayashi T; Takewaka T; Ito M; Niida S; Ikeda K
    Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
    Liesegang A; Reutter R; Sassi ML; Risteli J; Kraenzlin M; Riond JL; Wanner M
    Am J Vet Res; 1999 Aug; 60(8):949-53. PubMed ID: 10451203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary markers of type I collagen degradation in the dog.
    Allen MJ; Allen LC; Hoffmann WE; Richardson DC; Breur GJ
    Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical markers of bone turnover.
    Delmas PD
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S549-55. PubMed ID: 8122526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.